-
Ask the MD: New Parkinson’s Treatment Submitted to FDA for Approval
May 24, 2022
… the infusion site and involuntary, uncontrolled movement (dyskinesia). Another ongoing, open-label Phase III trial is …
-
Data Challenges
… Trial, which evaluated the use of a smartwatch to monitor dyskinesia (uncontrolled, involuntary movements) and "off" …
-
The Michael J. Fox Foundation for Parkinson's Research Confers Inaugural Bachmann-Strauss Prize for Excellence in Dystonia Research
May 13, 2015
… drugs used to treat Parkinson’s applicable to dystonia and dyskinesia, which is excessive movement caused by long-term …
-
The Michael J. Fox Foundation Awards $3 Million to Advance Parkinson's Disease Research
April 23, 2010
… Neoangiogenesis and Blood-Brain Barrier in L-DOPA-Induced Dyskinesia Angela Cenci-Nilsson, MD, PhD, Lund University …
-
MJFF Research Staff Reflects on Some of 2011's Big Impact Projects
December 24, 2011
… the development of treatments to reduce levodopa-induced dyskinesias , a critical unmet need for those living with …
-
In the Community: Assistive Devices for People with Parkinson’s Disease
June 5, 2023
… freezing of gait (a temporary inability to move) or dyskinesia (involuntary movement). Aspects of the … For individuals who experience excessive shuffling, dyskinesia or fatigue, a manual wheelchair can allow …